Many tests commonly used in clinical practice, which employ such well-known cancer-associated biomarkers as PSA (prostate cancer marker), CEA (colorectal cancer marker), α-fetoprotein (liver cancer marker), CA 125 (ovarian cancer marker) and CA 19-9 (pancreatic cancer marker), were reported to have insufficient sensitivity and specificity. Here, KLK3 is linked to cancer.